Lundbeck announces plans to cut a fifth of R&D workforceLundbeck has announced plans to cut its research and development team, which could lead to a reduction of Share XLundbeck announces plans to cut a fifth of R&D workforcehttps://pharmaphorum.com/news/lundbeck-announces-plans-to-cut-around-160-rd-jobs/
Roche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps inRoche’s influential chief medical officer Sandra Horning is to retire at the end of the year, the company Share XRoche’s CMO Horning to retire, Lilly’s high-flyer Garraway steps inhttps://pharmaphorum.com/news/roches-cmo-horning-to-retire/
Symonds confirmed as new GSK chairman amid CEO’s business rethinkGlaxoSmithKline has confirmed that it has hired Jonathan Symonds as chairman, confirming press speculation that the former Novartis Share XSymonds confirmed as new GSK chairman amid CEO’s business rethinkhttps://pharmaphorum.com/news/symonds-confirmed-as-new-gsk-chairman-amid-ceos-business-rethink/
Gottlieb joins Pfizer board, a few weeks after quitting FDAFormer FDA commissioner Scott Gottlieb has stoked controversy after being appointed to Pfizer’s board of directors, just a Share XGottlieb joins Pfizer board, a few weeks after quitting FDAhttps://pharmaphorum.com/news/gottlieb-joins-pfizer-board-a-few-weeks-after-quitting-fda/
Sanofi appoints former Novartis exec Hudson as CEOSanofi has appointed Novartis’ pharma chief Paul Hudson as chief executive to replace the retiring Olivier Brandicourt, prompting Share XSanofi appoints former Novartis exec Hudson as CEOhttps://pharmaphorum.com/news/sanofi-appoints-former-novartis-exec-hudson-as-ceo/
WriterThis is an exciting opportunity to join a high growth digital media company, which has both online publications Share XWriterhttps://pharmaphorum.com/jobs/writer-publishing-division/
GSK’s chairman Sir Philip Hampton steps downGlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in Share XGSK’s chairman Sir Philip Hampton steps downhttps://pharmaphorum.com/news/gsks-chairman-sir-philip-hampton-steps-down/
Gilead hires Roche’s pharma chief Daniel O’Day as CEORoche executive Daniel O’Day is to take the helm at Gilead after John Milligan steps down as CEO Share XGilead hires Roche’s pharma chief Daniel O’Day as CEOhttps://pharmaphorum.com/news/gilead-hires-roches-pharma-chief-daniel-oday-as-ceo/
CEO of UK drugs regulator quits, as Brexit nearsThe CEO of the UK’s medicine regulator has announced he will leave his post in September next year. Share XCEO of UK drugs regulator quits, as Brexit nearshttps://pharmaphorum.com/news/ceo-of-uk-drugs-regulator-quits-as-brexit-nears/
